cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2023-39-3-49-57cardiotomsk-1936Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESНативное Т1- и Т2-картирование времен релаксации миокарда при магнитно-резонансной томографии сердца: области примененияNative T1- and T2-mapping of myocardial relaxation times in cardiovascular magnetic resonance: clinical applicationshttps://orcid.org/0000-0002-1266-4926МершинаЕ. А.MershinaE. A.

Мершина Елена Александровна, канд. мед. наук, ведущий научный сотрудник, отдел лучевой диагностики, заведующий отделением рентгенодиагностики с кабинетами МРТ и КТ; доцент кафедры лучевой диагностики, факультет фундаментальной медицины

119192, Российская Федерация, Москва, Ломоносовский пр., 27, корп. 10

Elena A. Mershina, Cand. Sci. (Med.), PhD, Leading Research Scientist, Head of Radiology Department; Assistant Professor, Department of Radiology at the Faculty of Fundamental Medicine

27, corp. 1, Lomonosovsky pr., Moscow, 119991, Russian Federation

elena_mershina@mail.ruhttps://orcid.org/0000-0003-3629-0591РыжковаЕ. В.RyzhkovaE. V.

Рыжкова Евгения Викторовна, младший научный сотрудник, отдел клинической кардиологии, Национальный медицинский исследовательский центр терапии и профилактической медицины Министерства здравоохранения Российской Федерации; врач-кардиолог, врач лучевой диагностики (УЗД и рентгенология), Медицинский научно-образовательный центр, Московский государственный университет имени М.В. Ломоносова

119192, Российская Федерация, Москва, Ломоносовский пр., 27, корп. 10; 101990, Российская Федерация, Москва, Петроверигский пер., 10, стр. 3

Evgeniya V. Ryzhkova, Junior Research Scientist, Department of Clinical Cardiology

27, corp. 1, Lomonosovsky pr., Moscow, 119991, Russian Federation; 10, build. 3, Petroverigsky per., Moscow, 101990, Russian Federation

evgenia_ryzhkova@list.ruhttps://orcid.org/0000-0002-8402-7643ЛисицкаяМ. В.LisitskayaM. V.

Лисицкая Мария Валерьевна, канд. мед. наук, научный сотрудник, отдел лучевой диагностики, врач-рентгенолог отделения рентгенодиагностики с кабинетами МРТ и КТ

119192, Российская Федерация, Москва, Ломоносовский пр., 27, корп. 10

Maria V. Lisitskaya, Cand. Sci. (Med.), Research Scientist, Department of Radiation Diagnostics, Radiologist of the Department of X-ray Diagnostics with MRI and CT

27, corp. 1, Lomonosovsky pr., Moscow, 119991, Russian Federation

lissenok@inbox.ruhttps://orcid.org/0000-0002-6855-4857ХарлапМ. С.KharlapM. S.

Харлап Мария Сергеевна, канд. мед. наук, ведущий научный сотрудник, отдел нарушений сердечного ритма и проводимости

101990, Российская Федерация, Москва, Петроверигский пер., 10, стр. 3

Maria S. Kharlap, Cand. Sci. (Med.), Leading Research Scientist, Arrythmology Department

10, build. 3, Petroverigsky per., Moscow, 101990, Russian Federation

kharlapmaria@yahoo.comhttps://orcid.org/0000-0002-5649-2193СиницынВ. Е.SinitsynV. E.

Синицын Валентин Евгеньевич, д-р мед. наук, профессор, заведующий кафедрой лучевой диагностики и терапии, факультет фундаментальной медицины, заведующий отделом лучевой диагностики

119192, Российская Федерация, Москва, Ломоносовский пр., 27, корп. 10

Valentin E. Sinitsyn, Dr. Sci. (Med.), Professor, Head of the Department of Radiation Diagnostics and Therapy, Faculty of Fundamental Medicine, Head of the Department of Radiation Diagnostics

27, corp. 1, Lomonosovsky pr., Moscow, 119991, Russian Federation

vsini@mail.ruМосковский государственный университет имени М.В. Ломоносова, Медицинский научно-образовательный центрРоссияMedical Research and Education Center of Lomonosov Moscow State UniversityRussian FederationМосковский государственный университет имени М.В. Ломоносова, Медицинский научно-образовательный центр; Национальный медицинский исследовательский центр терапии и профилактической медицины Министерства здравоохранения Российской ФедерацииРоссияMedical Research and Education Center of Lomonosov Moscow State University; Federal State Budgetary Institution “National Medical Research Center for Therapy and Preventive Medicine” of the Ministry of Healthcare of the Russian FederationRussian FederationНациональный медицинский исследовательский центр терапии и профилактической медицины Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Institution “National Medical Research Center for Therapy and Preventive Medicine” of the Ministry of Healthcare of the Russian FederationRussian Federation2023101020233834957Copyright © Мершина Е.А., Рыжкова Е.В., Лисицкая М.В., Харлап М.С., Синицын В.Е., 20232023Мершина Е.А., Рыжкова Е.В., Лисицкая М.В., Харлап М.С., Синицын В.Е.Mershina E.A., Ryzhkova E.V., Lisitskaya M.V., Kharlap M.S., Sinitsyn V.E.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/1936

Магнитно-резонансная томография (МРТ) сердца широко применяется в диагностике сердечно-сосудистых заболеваний, так как позволяет неинвазивно оценить характер поражения тканей сердца. В последние годы в рутинную практику активно внедряются методы нативного картирования Т1- и Т2-времен релаксации миокарда. Нативное Т1-и Т2-картирование дает возможность количественного анализа состояния миокарда. Данная методика может быть использована для выявления и оценки широкого спектра поражений миокарда на различных этапах патологического процесса без необходимости контрастирования гадолиний-содержащими препаратами. В настоящем обзоре мы рассмотрим применение нативного Т1- и Т2-картрирования миокарда при различных заболеваниях сердца.

Cardiovascular magnetic resonance is widely used due to its possibilities for noninvasive cardiac tissue characterization. In recent years native myocardial T1- and T2-mapping techniques have been implemented in routine practice. These techniques provide quantitative analysis of myocardium and allow detection and evaluation of myocardial damage without the need for gadolinium-based contrast agents. In this review we would like to discuss application of native T1- and T2-mapping in different types of heart disease.

магнитно-резонансная томография сердцакартирование миокардазаболевания сердцаишемическая болезнь сердцакардиомиопатияамилоидозболезни накоплениямиокардитcardiovascular magnetic resonancemappingheart diseasecoronary artery diseasecardiomyopathyamyloidosisstorage diseasemyocarditisисследование выполнено в рамках Государственного задания Московского государственного университета имени М.В. Ломоносова.this study was supported by research project of the Moscow State University by M.V. Lomonosov.ReferencesKim P.K., Hong Y.J., Im D.J., Suh Y.J., Park C.H., Kim J.Y. et al. Myocardial T1 and T2 mapping: techniques and clinical applications. Korean J. Radiol. 2017;18(1):113–131. DOI: 10.3348/kjr.2017.18.1.113.Kim P.K., Hong Y.J., Im D.J., Suh Y.J., Park C.H., Kim J.Y. et al. Myocardial T1 and T2 mapping: techniques and clinical applications. Korean J. Radiol. 2017;18(1):113–131. DOI: 10.3348/kjr.2017.18.1.113.Piechnik S.K., Ferreira V.M., Lewandowski A.J., Ntusi N.A., Banerjee R., Holloway C. et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J. Cardiovasc. Magn. Reson. 2013;15(1):13. DOI: 10.1186/1532-429X-15-13.Piechnik S.K., Ferreira V.M., Lewandowski A.J., Ntusi N.A., Banerjee R., Holloway C. et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J. Cardiovasc. Magn. Reson. 2013;15(1):13. DOI: 10.1186/1532-429X-15-13.Mewton N., Liu C.Y., Croisille P., Bluemke D., Lima J.A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2011;57:891–903. DOI: 10.1016/j.jacc.2010.11.013.Mewton N., Liu C.Y., Croisille P., Bluemke D., Lima J.A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2011;57:891–903. DOI: 10.1016/j.jacc.2010.11.013.Radunski U.K., Lund G.K., Stehning C., Schnackenburg B., Bohnen S., Adam G. et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc. Imaging. 2014;7(7):667–675. DOI: 10.1016/j.jcmg.2014.02.005.Radunski U.K., Lund G.K., Stehning C., Schnackenburg B., Bohnen S., Adam G. et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc. Imaging. 2014;7(7):667–675. DOI: 10.1016/j.jcmg.2014.02.005.Piechnik S.K., Ferreira V.M., Dall’Armellina E., Cochlin L.E., Greiser A., Neubauer S. et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J. Cardiovasc. Magn. Reson. 2010;12(1):69. DOI: 10.1186/1532-429X-12-69.Piechnik S.K., Ferreira V.M., Dall’Armellina E., Cochlin L.E., Greiser A., Neubauer S. et al. Shortened Modifi ed Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J. Cardiovasc. Magn. Reson. 2010;12(1):69. DOI: 10.1186/1532-429X-12-69.Chow K., Flewitt J.A., Green J.D., Pagano J.J., Friedrich M.G., Thompson R.B. Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn. Reson. Med. 2014;71(6):2082–2095. DOI: 10.1002/mrm.24878.Chow K., Flewitt J.A., Green J.D., Pagano J.J., Friedrich M.G., Thompson R.B. Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn. Reson. Med. 2014;71(6):2082–2095. DOI: 10.1002/mrm.24878.Messroghli D.R., Greiser A., Fröhlich M., Dietz R., Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified Look-Locker inversion-recovery (MOLLI) T1 mapping of the heart. J. Magn. Reson. Imaging. 2007;26(4):1081–1086. DOI: 10.1002/jmri.21119.Messroghli D.R., Greiser A., Fröhlich M., Dietz R., Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified Look-Locker inversion-recovery (MOLLI) T1 mapping of the heart. J. Magn. Reson. Imaging. 2007;26(4):1081–1086. DOI: 10.1002/jmri.21119.Messroghli D.R., Radjenovic A., Kozerke S., Higgins D.M., Sivananthan M.U., Ridgway J.P. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn. Reson. Med. 2004;52(1):141–146. DOI: 10.1002/mrm.20110.Messroghli D.R., Radjenovic A., Kozerke S., Higgins D.M., Sivananthan M.U., Ridgway J.P. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn. Reson. Med. 2004;52(1):141–146. DOI: 10.1002/mrm.20110.Weingärtner S., Akçakaya M., Basha T., Kissinger K.V., Goddu B., Berg S. et al. Combined saturation / inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn. Reson. Med. 2014;71(3):1024–1034. DOI: 10.1002/mrm.24761.Weingärtner S., Akçakaya M., Basha T., Kissinger K.V., Goddu B., Berg S. et al. Combined saturation / inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn. Reson. Med. 2014;71(3):1024–1034. DOI: 10.1002/mrm.24761.O’Brien A.T., Gil K.E., Varghese J., Simonetti O.P., Zareba K.M. T2 mapping in myocardial disease: a comprehensive review. J. Cardiovasc. Magn. Reson. 2022;24(1):33. DOI: 10.1186/s12968-022-00866-0.O’Brien A.T., Gil K.E., Varghese J., Simonetti O.P., Zareba K.M. T2 mapping in myocardial disease: a comprehensive review. J. Cardiovasc. Magn. Reson. 2022;24(1):33. DOI: 10.1186/s12968-022-00866-0.Willerson J.T., Scales F., Mukherjee A., Platt M., Templeton G.H., Fink G.S. et al. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am. J. Pathol. 1977;87(1):159–188.Willerson J.T., Scales F., Mukherjee A., Platt M., Templeton G.H., Fink G.S. et al. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am. J. Pathol. 1977;87(1):159–188.Wisenberg G., Prato F.S., Carroll S.E., Turner K.L., Marshall T. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am. Heart J. 1988;115(3):510–518. DOI: 10.1016/0002-8703(88)90798-3.Wisenberg G., Prato F.S., Carroll S.E., Turner K.L., Marshall T. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am. Heart J. 1988;115(3):510–518. DOI: 10.1016/0002-8703(88)90798-3.Ugander M., Bagi P.S., Oki A.J., Chen B., Hsu L.Y., Aletras A., et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc. Imaging. 2012;5(6):596–603. DOI: 10.1016/j.jcmg.2012.01.016.Ugander M., Bagi P.S., Oki A.J., Chen B., Hsu L.Y., Aletras A., et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc. Imaging. 2012;5(6):596–603. DOI: 10.1016/j.jcmg.2012.01.016.Goldfarb J.W., Arnold S., Han J. Recent myocardial infarction: assessment with unenhanced T1-weighted MR imaging. Radiology. 2007;245(1):245–250. DOI: 10.1148/radiol.2451061590.Goldfarb J.W., Arnold S., Han J. Recent myocardial infarction: assessment with unenhanced T1-weighted MR imaging. Radiology. 2007;245(1):245–250. DOI: 10.1148/radiol.2451061590.Bulluck H., White S.K., Rosmini S., Bhuva A., Treibel T.A., Fontana M. et al. T1 mapping and T2 mapping at 3T for quantifying the area-atrisk in reperfused STEMI patients. J. Cardiovasc. Magn. Reson. 2015;12;17(1):73. DOI: 10.1186/s12968-015-0173-6.Bulluck H., White S.K., Rosmini S., Bhuva A., Treibel T.A., Fontana M. et al. T1 mapping and T2 mapping at 3T for quantifying the area-atrisk in reperfused STEMI patients. J. Cardiovasc. Magn. Reson. 2015;12;17(1):73. DOI: 10.1186/s12968-015-0173-6.Zia M.I., Ghugre N.R., Connelly K.A., Strauss B.H., Sparkes J.D., Dick A.J. et al. Characterizing myocardial edema and hemorrhage using quantitative T2 and T2* mapping at multiple time intervals post ST-segment elevation myocardial infarction. Circ. Cardiovasc. Imaging. 2012;5(5):566–572. DOI: 10.1161/CIRCIMAGING.112.973222.Zia M.I., Ghugre N.R., Connelly K.A., Strauss B.H., Sparkes J.D., Dick A.J. et al. Characterizing myocardial edema and hemorrhage using quantitative T2 and T2* mapping at multiple time intervals post ST-segment elevation myocardial infarction. Circ. Cardiovasc. Imaging. 2012;5(5):566–572. DOI: 10.1161/CIRCIMAGING.112.973222.Suranyi P., Elgavish G.A., Schoepf U.J., Ruzsics B., Kiss P., van Assen M. et al. Myocardial tissue characterization by combining late gadolinium enhancement imaging and percent edema mapping: a novel T2 map-based MRI method in canine myocardial infarction. Eur. Radiol. Exp. 2018;2(1):6. DOI: 10.1186/s41747-018-0037-6.Suranyi P., Elgavish G.A., Schoepf U.J., Ruzsics B., Kiss P., van Assen M. et al. Myocardial tissue characterization by combining late gadolinium enhancement imaging and percent edema mapping: a novel T2 map-based MRI method in canine myocardial infarction. Eur. Radiol. Exp. 2018;2(1):6. DOI: 10.1186/s41747-018-0037-6.Tahir E., Sinn M., Bohnen S., Avanesov M., Säring D., Stehning C. et al. Acute versus chronic myocardial infarction: diagnostic accuracy of quantitative native T1 and T2 mapping versus assessment of edema on standard T2-weighted cardiovascular MR images for differentiation. Radiology. 2017;285(1):83–91. DOI: 10.1148/radiol.2017162338.Tahir E., Sinn M., Bohnen S., Avanesov M., Säring D., Stehning C. et al. Acute versus chronic myocardial infarction: diagnostic accuracy of quantitative native T1 and T2 mapping versus assessment of edema on standard T2-weighted cardiovascular MR images for differentiation. Radiology. 2017;285(1):83–91. DOI: 10.1148/radiol.2017162338.Carrick D., Haig C., Ahmed N., McEntegart M., Petrie M.C., Eteiba H. et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ. Cardiovasc. Imaging. 2016;9(1):e004148. DOI: 10.1161/CIRCIMAGING.115.004148.Carrick D., Haig C., Ahmed N., McEntegart M., Petrie M.C., Eteiba H. et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ. Cardiovasc. Imaging. 2016;9(1):e004148. DOI: 10.1161/CIRCIMAGING.115.004148.Liu A., Wijesurendra R.S., Francis J.M., Robson M.D., Neubauer S., Piechnik S.K., Ferreira V.M. Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents. JACC Cardiovasc. Imaging. 2016;9(1):27–36. DOI: 10.1016/j.jcmg.2015.08.018.Liu A., Wijesurendra R.S., Francis J.M., Robson M.D., Neubauer S., Piechnik S.K., Ferreira V.M. Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast fgents. JACC Cardiovasc. Imaging. 2016;9(1):27–36. DOI: 10.1016/j.jcmg.2015.08.018.Burrage M.K., Shanmuganathan M., Zhang, Q., Hann E., Popescu I.A., Soundarajan R. et al. Cardiac stress T1-mapping response and extracellular volume stability of MOLLI-based T1-mapping methods. Sci. Rep. 2021;11(1):13568. DOI: 10.1038/s41598-021-92923-4.Burrage M.K., Shanmuganathan M., Zhang, Q., Hann E., Popescu I.A., Soundarajan R. et al. Cardiac stress T1-mapping response and extracellular volume stability of MOLLI-based T1-mapping methods. Sci. Rep. 2021;11(1):13568. DOI: 10.1038/s41598-021-92923-4.Mewton N., Liu C.Y., Croisille P., Bluemke D., Lima J.A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2011;57(8):891–903. DOI: 10.1016/j.jacc.2010.11.013.Mewton N., Liu C.Y., Croisille P., Bluemke D., Lima J.A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2011;57(8):891–903. DOI: 10.1016/j.jacc.2010.11.013.Mordi I., Carrick D., Bezerra H., Tzemos N. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur. Heart J. Cardiovasc. Imaging. 2016;17(7):797–803. DOI: 10.1093/ehjci/jev216.Mordi I., Carrick D., Bezerra H., Tzemos N. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur. Heart J. Cardiovasc. Imaging. 2016;17(7):797–803. DOI: 10.1093/ehjci/jev216.Nishii T., Kono A.K., Shigeru M., Takamine S., Fujiwara S., Kyotani K. et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. Int. J. Cardiovasc. Imaging. 2014;30 Suppl. 1:65–72. DOI: 10.1007/s10554-014-0414-z.Nishii T., Kono A.K., Shigeru M., Takamine S., Fujiwara S., Kyotani K. et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. Int. J. Cardiovasc. Imaging. 2014;30 Suppl. 1:65–72. DOI: 10.1007/s10554-014-0414-z.Jeserich M., Föll D., Olschewski M. Kimmel S., Friedrich M.G., Bode C. et al. Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy. Clin. Cardiol. 2012;35(6):371–376. DOI: 10.1002/clc.21979.Jeserich M., Föll D., Olschewski M. Kimmel S., Friedrich M.G., Bode C. et al. Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy. Clin. Cardiol. 2012;35(6):371–376. DOI: 10.1002/clc.21979.Spieker M., Katsianos E., Gastl M., Behm P., Horn P., Jacoby C. et al. T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy. Eur. Heart J. Cardiovasc. Imaging. 2018;19(5):574–582. DOI: 10.1093/ehjci/jex230.Spieker M., Katsianos E., Gastl M., Behm P., Horn P., Jacoby C. et al. T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy. Eur. Heart J. Cardiovasc. Imaging. 2018;19(5):574–582. DOI: 10.1093/ehjci/jex230.Xu Y., Li W., Wan K., Liang Y., Jiang X., Wang J. et al. Myocardial tissue reverse remodeling after guideline-directed medical therapy in idiopathic dilated cardiomyopathy. Circ. Heart Fail. 2021;14(1):e007944. DOI: 10.1161/CIRCHEARTFAILURE.120.007944.Xu Y., Li W., Wan K., Liang Y., Jiang X., Wang J. et al. Myocardial tissue reverse remodeling after guideline-directed medical therapy in idiopathic dilated cardiomyopathy. Circ. Heart Fail. 2021;14(1):e007944. DOI: 10.1161/CIRCHEARTFAILURE.120.007944.Caforio A.L., Pankuweit S., Arbustini E., Basso C., Gimeno-Blanes J., Felix S.B. et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013;34(33):2636– 2648, 2648a–2648d. DOI: 10.1093/eurheartj/eht210.Caforio A.L., Pankuweit S., Arbustini E., Basso C., Gimeno-Blanes J., Felix S.B. et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013;34(33):2636– 2648, 2648a–2648d. DOI: 10.1093/eurheartj/eht210.Spieker M., Haberkorn S., Gastl M., Behm P., Katsianos S., Horn P. et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J. Cardiovasc. Magn. Reson. 2017;19(1):38. DOI: 10.1186/s12968-017-0350-x.Spieker M., Haberkorn S., Gastl M., Behm P., Katsianos S., Horn P. et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J. Cardiovasc. Magn. Reson. 2017;19(1):38. DOI: 10.1186/s12968-017-0350-x.Lurz P., Luecke C., Eitel I., Föhrenbach F., Frank C., Grothoff M. et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the myoracer-trial. J. Am. Coll. Cardiol. 2016;67(15):1800–1811. DOI: 10.1016/j.jacc.2016.02.013.Lurz P., Luecke C., Eitel I., Föhrenbach F., Frank C., Grothoff M. et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the myoracer-trial. J. Am. Coll. Cardiol. 2016;67(15):1800–1811. DOI: 10.1016/j.jacc.2016.02.013.Tschöpe C., Ammirati E., Bozkurt B., Caforio A.L.P., Cooper L.T., Felix S.B. et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat. Rev. Cardiol. 2021;18(3):169–193. DOI: 10.1038/s41569-020-00435-x.Tschöpe C., Ammirati E., Bozkurt B., Caforio A.L.P., Cooper L.T., Felix S.B. et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat. Rev. Cardiol. 2021;18(3):169–193. DOI: 10.1038/s41569-020-00435-x.Bönner F., Spieker M., Haberkorn S., Jacoby C., Flögel U., Schnackenburg B. et al. Myocardial T2 mapping increases noninvasive diagnostic accuracy for biopsy-proven myocarditis. JACC Cardiovasc. Imaging. 2016;9(12):1467–1469. DOI: 10.1016/j.jcmg.2015.11.014.Bönner F., Spieker M., Haberkorn S., Jacoby C., Flögel U., Schnackenburg B. et al. Myocardial T2 mapping increases noninvasive diagnostic accuracy for biopsy-proven myocarditis. JACC Cardiovasc. Imaging. 2016;9(12):1467–1469. DOI: 10.1016/j.jcmg.2015.11.014.Hinojar R., Foote L., Arroyo Ucar E., Jackson T., Jabbour A., Yu C.Y. et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc. Imaging. 2015;8(1):37–46. DOI: 10.1016/j.jcmg.2014.07.016.Hinojar R., Foote L., Arroyo Ucar E., Jackson T., Jabbour A., Yu C.Y. et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc. Imaging. 2015;8(1):37–46. DOI: 10.1016/j.jcmg.2014.07.016.Ferreira V.M., Piechnik S.K., Dall’Armellina E., Karamitsos T.D., Francis J.M., Ntusi N. et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc. Imaging. 2013;6(10):1048–1058. DOI: 10.1016/j.jcmg.2013.03.008.Ferreira V.M., Piechnik S.K., Dall’Armellina E., Karamitsos T.D., Francis J.M., Ntusi N. et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc. Imaging. 2013;6(10):1048–1058. DOI: 10.1016/j.jcmg.2013.03.008.Ferreira V.M., Piechnik S.K., Dall’Armellina E., Karamitsos T.D., Francis J.M., Ntusi N. et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J. Cardiovasc. Magn. Reson. 2014;16(1):36. DOI: 10.1186/1532-429X-16-36.Ferreira V.M., Piechnik S.K., Dall’Armellina E., Karamitsos T.D., Francis J.M., Ntusi N. et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J. Cardiovasc. Magn. Reson. 2014;16(1):36. DOI: 10.1186/1532-429X-16-36.Spieker M., Haberkorn S., Gastl M., Behm P., Katsianos S., Horn P. et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J. Cardiovasc. Magn. Reson. 2017;19(1):38. DOI: 10.1186/s12968-017-0350-x.Spieker M., Haberkorn S., Gastl M., Behm P., Katsianos S., Horn P. et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J. Cardiovasc. Magn. Reson. 2017;19(1):38. DOI: 10.1186/s12968-017-0350-x.Bohnen S., Radunski U.K., Lund G.K., Kandolf R., Stehning C., Schnackenburg B. et al. Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ. Cardiovasc. Imaging. 2015;8(6):e003073. DOI: 10.1161/CIRCIMAGING.114.003073.Bohnen S., Radunski U.K., Lund G.K., Kandolf R., Stehning C., Schnackenburg B. et al. Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ. Cardiovasc. Imaging. 2015;8(6):e003073. DOI: 10.1161/CIRCIMAGING.114.003073.Мершина Е.А., Синицын В.Е., Ларина О.М. Магнитно-резонансная томография сердца в диагностике гипертрофической кардиомиопатии и стратификации риска внезапной сердечной смерти. Клин. и эксперимент. хир. Журн. им. акад. Б.В. Петровского. 2019;7(3):70–78. DOI: 10.24411/2308-1198-2019-13008.Mershina E.A., Sinitsyn V.E., Larina O.M. Cardiac magnetic resonance in diagnosis of hypertrophic cardiomyopathy and sudden cardiac death risk stratification. Clin. Experiment. Surg. Petrovsky J. 2019;7(3):70–78. (In Russ.) DOI: 10.24411/2308-1198-2019-13008.Баев М.С., Рыжков А.В., Гаврилова Е.А., Труфанов Г.Е. Клиническое применение Т1-картирования миокарда: обзор литературы и первый опыт клинического применения. Сибирский журнал клинической и экспериментальной медицины. 2022;37(1):17–26. DOI: 10.29001/2073-8552-2022-37-1-17-26.Baev M.S., Ryzhkov A.V., Gavrilova E.A., Trufanov G.E. Clinical application of T1-myocardial mapping: Review of literature and first experience of clinical application. The Siberian Journal of Clinical and Experimental Medicine. 2022;37(1):17–26. (In Russ.) DOI: 10.29001/2073-8552-2022-37-1-17-26.Małek Ł.A., Werys K., Kłopotowski M., Spiewak M., Miłosz-Wieczorek B., Mazurkiewicz Ł. et al. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy – comparison with late enhancement quantification. Magn. Reson. Imaging. 2015;33(6):718–724. DOI: 10.1016/j.mri.2015.04.001.Małek Ł.A., Werys K., Kłopotowski M., Spiewak M., Miłosz-Wieczorek B., Mazurkiewicz Ł. et al. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy – comparison with late enhancement quantifi cation. Magn. Reson. Imaging. 2015;33(6):718–724. DOI: 10.1016/j.mri.2015.04.001.Huang L., Ran L., Zhao P., Tang D., Han R., Ai T. et al. MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes. Br. J. Radiol. 2019;92(1104):20190634. DOI: 10.1259/bjr.20190634.Huang L., Ran L., Zhao P., Tang D., Han R., Ai T. et al. MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes. Br. J. Radiol. 2019;92(1104):20190634. DOI: 10.1259/bjr.20190634.Baig M., Galazka P., Dakwar O., Syed S.A., Sawlani R., Shahir K. et al. Prevalence of myocardial edema with T2-mapping in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2021;77(18 Suppl. 1):1303. DOI: 10.1016/s0735-1097(21)02661-9.Baig M., Galazka P., Dakwar O., Syed S.A., Sawlani R., Shahir K. et al. Prevalence of myocardial edema with T2-mapping in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2021;77(18 Suppl. 1):1303. DOI: 10.1016/s0735-1097(21)02661-9.Ridouani F., Damy T., Tacher V., Derbel H., Legou F., Sifaoui I. et al. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis. J. Cardiovasc. Magn. Reson. 2018;20(1):58. DOI: 10.1186/s12968-018-0478-3.Ridouani F., Damy T., Tacher V., Derbel H., Legou F., Sifaoui I. et al. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis. J. Cardiovasc. Magn. Reson. 2018;20(1):58. DOI: 10.1186/s12968-018-0478-3.Pan J.A., Kerwin M.J., Salerno M. Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis. JACC Cardiovasc. Imaging. 2020;13(6):1299–1310. DOI: 10.1016/j.jcmg.2020.03.010.Pan J.A., Kerwin M.J., Salerno M. Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis. JACC Cardiovasc. Imaging. 2020;13(6):1299–1310. DOI: 10.1016/j.jcmg.2020.03.010.Banypersad S.M. The evolving role of cardiovascular magnetic resonance imaging in the evaluation of systemic amyloidosis. Magn. Reson. Insights. 2019;12:1178623X19843519. DOI: 10.1177/1178623X19843519.Banypersad S.M. The evolving role of cardiovascular magnetic reso-nance imaging in the evaluation of systemic amyloidosis. Magn. Reson. Insights. 2019;12:1178623X19843519. DOI: 10.1177/1178623X19843519.Slivnick J.A., Tong M.S., Nagaraja H.N., Elamin M.B., Wallner A., O’Brien A. et al. Novel cardiovascular magnetic resonance model to distinguish immunoglobulin light chain from transthyretin cardiac amyloidosis. JACC Cardiovasc. Imaging. 2021;14(1):302–304. DOI: 10.1016/j.jcmg.2020.07.030.Slivnick J.A., Tong M.S., Nagaraja H.N., Elamin M.B., Wallner A., O’Brien A. et al. Novel cardiovascular magnetic resonance model to distinguish immunoglobulin light chain from transthyretin cardiac amyloidosis. JACC Cardiovasc. Imaging. 2021;14(1):302–304. DOI: 10.1016/j.jcmg.2020.07.030.Kotecha T., Martinez-Naharro A., Treibel T.A, Francis R., Nordin S., Abdel-Gadir A. et al. Myocardial edema and prognosis in amyloidosis. J. Am. Coll. Cardiol. 2018;71(25):2919–2931. DOI: 10.1016/j.jacc.2018.03.536.Kotecha T., Martinez-Naharro A., Treibel T.A, Francis R., Nordin S., Abdel-Gadir A. et al. Myocardial edema and prognosis in amyloidosis. J. Am. Coll. Cardiol. 2018;71(25):2919–2931. DOI: 10.1016/j.jacc.2018.03.536.Kampmann C., Linhart A., Baehner F., Palecek T., Wiethoff C.M., Miebach E. et al. Onset and progression of the Anderson-Fabry disease related cardiomyopathy. Int. J. Cardiol. 2008;130(3):367–373. DOI: 10.1016/j.ijcard.2008.03.007.Kampmann C., Linhart A., Baehner F., Palecek T., Wiethoff C.M., Miebach E. et al. Onset and progression of the Anderson-Fabry disease related cardiomyopathy. Int. J. Cardiol. 2008;130(3):367–373. DOI: 10.1016/j.ijcard.2008.03.007.Krämer J., Niemann M., Störk S., Frantz S., Beer M., Ertl G. et al. Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. Am. J. Cardiol. 2014;114(6):895–900. DOI: 10.1016/j.amjcard.2014.06.019.Krämer J., Niemann M., Störk S., Frantz S., Beer M., Ertl G. et al. Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. Am. J. Cardiol. 2014;114(6):895–900. DOI: 10.1016/j.amjcard.2014.06.019.Patel V., O’Mahony C., Hughes D., Rahman M.S., Coats C., Murphy E. et al. Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease. Heart. 2015;101(12):961–966. DOI: 10.1136/heartjnl-2014-306782.Patel V., O’Mahony C., Hughes D., Rahman M.S., Coats C., Murphy E. et al. Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease. Heart. 2015;101(12):961–966. DOI: 10.1136/heartjnl-2014-306782.Germain D.P., Charrow J., Desnick R.J., Guffon N., Kempf J., Lachmann R.H. et al. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J. Med. Genet. 2015;52(5):353–358. DOI: 10.1136/jmedgenet-2014-102797.Germain D.P., Charrow J., Desnick R.J., Guffon N., Kempf J., Lachmann R.H. et al. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J. Med. Genet. 2015;52(5):353–358. DOI: 10.1136/jmedgenet-2014-102797.Motwani M., Banypersad S., Woolfson P., Waldek S. Enzyme replacement therapy improves cardiac features and severity of Fabry disease. Mol. Genet. Metab. 2012;107(1–2):197–202. DOI: 10.1016/j.ymgme.2012.05.011.Motwani M., Banypersad S., Woolfson P., Waldek S. Enzyme replacement therapy improves cardiac features and severity of Fabry disease. Mol. Genet. Metab. 2012;107(1–2):197–202. DOI: 10.1016/j.ymgme.2012.05.011.Beck M., Hughes D., Kampmann C., Larroque S., Mehta A., Pintos-Morell G., et al.; Fabry Outcome Survey Study Group. Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis. Mol. Genet. Metab. Rep. 2015;3:21–27. DOI: 10.1016/j.ymgmr.2015.02.002.Beck M., Hughes D., Kampmann C., Larroque S., Mehta A., Pintos-Morell G., et al.; Fabry Outcome Survey Study Group. Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis. Mol. Genet. Metab. Rep. 2015;3:21–27. DOI: 10.1016/j.ymgmr.2015.02.002.Moon J.C., Sachdev B., Elkington A.G., McKenna W.J., Mehta A., Pennell D.J. et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur. Heart J. 2003;24(23):2151–2155. DOI: 10.1016/j.ehj.2003.09.017.Moon J.C., Sachdev B., Elkington A.G., McKenna W.J., Mehta A., Pennell D.J. et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specifi c abnormality of the myocardial interstitium. Eur. Heart J. 2003;24(23):2151–2155. DOI: 10.1016/j.ehj.2003.09.017.Militaru S., Ginghina C., Popescu B.A., Saftoiu A., Linhart A., Jurcut R. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets. Eur. Heart J. Cardiovasc. Imaging. 2018;19(12):1313–1322. DOI: 10.1093/ehjci/jey132.Militaru S., Ginghina C., Popescu B.A., Saftoiu A., Linhart A., Jurcut R. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets. Eur. Heart J. Cardiovasc. Imaging. 2018;19(12):1313–1322. DOI: 10.1093/ehjci/jey132.Nordin S., Kozor R., Bulluck H., Castelletti S., Rosmini S., Abdel-Gadir A. et al. Cardiac fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy. J. Am. Coll. Cardiol. 2016;68(15):1707–1708. DOI: 10.1016/j.jacc.2016.07.741.Nordin S., Kozor R., Bulluck H., Castelletti S., Rosmini S., Abdel-Gadir A. et al. Cardiac fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy. J. Am. Coll. Cardiol. 2016;68(15):1707–1708. DOI: 10.1016/j.jacc.2016.07.741.Messroghli D.R., Moon J.C., Ferreira V.M., Grosse-Wortmann L., He T., Kellman P. et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J. Cardiovasc. Magn. Reson. 2017;19(1):75. DOI: 10.1186/s12968-017-0389-8.Messroghli D.R., Moon J.C., Ferreira V.M., Grosse-Wortmann L., He T., Kellman P. et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J. Cardiovasc. Magn. Reson. 2017;19(1):75. DOI: 10.1186/s12968-017-0389-8.Sado D.M., Maestrini V., Piechnik S.K., Banypersad S.M., White S.K., Flett A.S. et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. J. Magn. Reson. Imaging. 2015;41(6):1505–1511. DOI: 10.1002/jmri.24727.Sado D.M., Maestrini V., Piechnik S.K., Banypersad S.M., White S.K., Flett A.S. et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. J. Magn. Reson. Imaging. 2015;41(6):1505–1511. DOI: 10.1002/jmri.24727.Torlasco C., Cassinerio E., Roghi A., Faini A., Capecchi M., Abdel-Gadir A. et al. Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment. PLoS One. 2018;13(2):e0192890. DOI: 10.1371/journal.pone.0192890.Torlasco C., Cassinerio E., Roghi A., Faini A., Capecchi M., Abdel-Gadir A. et al. Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment. PLoS One. 2018;13(2):e0192890. DOI: 10.1371/journal.pone.0192890.Krittayaphong R., Zhang S., Saiviroonporn P., Viprakasit V., Tanapibunpon P., Komoltri C. et al. Detection of cardiac iron overload with native magnetic resonance T1 and T2 mapping in patients with thalassemia. Int. J. Cardiol. 2017;248:421–426. DOI: 10.1016/j.ijcard.2017.06.100.Krittayaphong R., Zhang S., Saiviroonporn P., Viprakasit V., Tanapibunpon P., Komoltri C. et al. Detection of cardiac iron overload with native magnetic resonance T1 and T2 mapping in patients with thalassemia. Int. J. Cardiol. 2017;248:421–426. DOI: 10.1016/j.ijcard.2017.06.100.

The authors declare that there are no conflicts of interest present.